Keuren Jeffrey F W, Ulrichts Hans, Feijge Marion A H, Hamulyak Karly, Deckmyn Hans, Lindhout Theo, Heemskerk Johan W M
Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, The Netherlands.
J Lab Clin Med. 2003 May;141(5):350-8. doi: 10.1016/S0022-2143(03)00004-0.
Under conditions of arterial-wall shear rates, platelets bind to von Willebrand factor (vWf) by way of the glycoprotein Ib (GP Ib) complex and integrin alpha(IIb)beta(3). Both adhesive receptors may also play roles in the development of procoagulant activity of platelets. Here, we investigated the effect of shear stress, as provided by a rotating cylinder, on GP Ib- and integrin alpha(IIb)beta(3)-dependent thrombin generation in coagulating platelet-rich plasma (PRP). We measured thrombin continuously with the use of fluorometry from the cleavage rate of a fluorescent low-affinity substrate. The integrin alpha(IIb)beta(3) antagonist abciximab progressively reduced the peak of thrombin formation up to 43% when rate of stirring and shear stress were increased (estimated shear rates of 105-420 s(-1)). Abciximab did not lower the peak of thrombin formation in stirred PRP from patients with Glanzmann's thrombasthenia lacking alpha(IIb)beta(3) but, surprisingly, shortened the time until onset. In PRP from control subjects, antibodies specifically directed against vWf-binding epitopes on GP Ibalpha reduced thrombin formation, with 25% to 30% at the high but not at the low stirring rate. In combination with the anti-GP Ib antibody, abciximab retained its strong inhibitory effect only at the high stirring rate. We conclude that thrombin formation and coagulation in stirred PRP depend, to a large extent, on platelet adhesion to integrin alpha(IIb)beta(3) and, in a shear-dependent way, on GP Ib.
在动脉壁剪切速率条件下,血小板通过糖蛋白Ib(GP Ib)复合物和整合素α(IIb)β3与血管性血友病因子(vWf)结合。这两种黏附受体在血小板促凝活性的发展中也可能发挥作用。在此,我们研究了旋转圆柱体提供的剪切应力对富含血小板血浆(PRP)凝固过程中GP Ib和整合素α(IIb)β3依赖性凝血酶生成的影响。我们通过荧光法从荧光低亲和力底物的裂解速率连续测量凝血酶。当搅拌速率和剪切应力增加(估计剪切速率为105 - 420 s(-1))时,整合素α(IIb)β3拮抗剂阿昔单抗逐渐将凝血酶形成的峰值降低多达43%。阿昔单抗并未降低来自缺乏α(IIb)β3的Glanzmann血小板无力症患者的搅拌PRP中的凝血酶形成峰值,但令人惊讶的是,缩短了起始时间。在来自对照受试者的PRP中,特异性针对GP Ibalpha上vWf结合表位的抗体减少了凝血酶形成,在高搅拌速率下降低了25%至30%,但在低搅拌速率下未降低。与抗GP Ib抗体联合使用时,阿昔单抗仅在高搅拌速率下保留其强大的抑制作用。我们得出结论,搅拌PRP中的凝血酶形成和凝血在很大程度上取决于血小板与整合素α(IIb)β3的黏附,并以剪切依赖的方式取决于GP Ib。